經驗死亡表 的英文怎麼說

中文拼音 [jīngyànwángbiǎo]
經驗死亡表 英文
experience table
  • : 經動詞[紡織] (把紡好的紗或線梳整成經紗或經線) warp
  • : 動詞1. (察看; 查考) examine; check; test 2. (產生預期的效果) prove effective; produce the expected result
  • : Ⅰ動詞(失去生命) die Ⅱ形容詞1 (不顧生命; 拚死) to the death 2 (達到極點) extremely; to death...
  • : Ⅰ動詞1 (逃跑) flee; escape; run away 2 (失去; 丟去) lose; be gone 3 (死) die; perish; pass ...
  • : Ⅰ名詞1 (外面;外表) outside; surface; external 2 (中表親戚) the relationship between the child...
  • 經驗 : 1 (由實踐得來的知識或技能) experience 2 (經歷) go through; experience; 經驗教訓 lessons from ...
  • 死亡 : die; breathe one s last; death; doom; dysthanasia; abiosis; end; meet one s death; the last [long...
  1. Thus this stage is also described in alchemical texts as the blackening, the nigredo experience, and it is often pictured as a death process, as in the caput mortuum, the deaths head, or as some alchemical illustrations show, the alchemist dying within a flask

    因此,這個階段在煉金術文獻裏面也描繪成致黑,黑斑蚧的體,也常被描繪成的進程,就像在大量的通知獵物已的號角聲一樣,的頭,或者就像一些煉金術圖像所示,煉金術士在長頸瓶內的
  2. Cdc5 gene is necessary for the g2 / m transition. cells with mutations in cdc5 can not finish the g2 / m transition, then die ; overexpression of cdc5 can shorten g2, the cell cycle as well. it also makes cells lessening

    1976年, nurse等在篩選裂殖酵母( s . pombe )細胞周期進程突變體的過程中得到了基因cdc5 ,后來證明cdc5對細胞周期g2期到m期的轉換是必需的: cdc5突變后造成細胞無法完成g2 m轉換而;過量達cdc5會縮短g2期,同時縮短整個細胞周期,並導致細胞變小。
  3. While the relationship between osa and increased cardioascular morbidity and mortality is well - known, this is the first study to examine the association between daytime sleepiness and cardiac hemodynamic performance in patients without established cardioascular disease

    雖然阻塞性睡眠呼吸暫停與心血管病的發病率和率的增加的關系已眾所周知,這個實第一次在未確診有心血管疾病的患者中研究白天嗜睡與心臟血流動力學現二者之間的關系。
  4. 5 d, the gray value of positive nerve cells began to increase and reached the peak point in the group of

    本實即刻組的陽性神細胞bfgf達最強,傷后lid內隨時間的增加其達不斷下降。
  5. The purposes of this study were to gain local experience, to find out the efficacy and side effects of surfactant and to find out whether surfactant therapy will lower the mortality and morbidity of premature infants

    摘要此一臨床試的目的在於得到本地的面張力素能否減少早?兒和率及合併癥。
分享友人